Device Trial Radar · NCT07143019
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
214
Planned (sponsor's estimate)
Start
Mar 16, 2026
Primary completion
Jul 2027
Study completion Jul 2032
Sponsor
- Lead sponsor
- phenox Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Phenox GmbH
- First posted
- Aug 27, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC Flow Modulation Device in the treatment of wide-necked intracranial aneurysms.
Conditions
- Hemorrhagic Stroke
- Aneurysm, Intracranial
- Saccular Aneurysm
- Fusiform Aneurysm
- Brain Aneurysm
Interventions
Flow diversionDevice
The p48 MW HPC and p64 MW HPC Flow Modulation Device is indicated for use in the treatment of intracranial aneurysms (IAs) arising from a parent vessel with a diameter of ≥2.0mm and ≤5.0 mm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Efficacy and Performance Endpoint: Number of subjects with 100% occlusion of the target aneurysm without significant parent artery stenosis and no retreatment of the target aneurysm from the index procedure to the 12-month follow-up visit.Time frame: 12 months
- The Primary Safety Endpoint: Number of subjects with ischemic or hemorrhagic stroke or neurologic death from treatment to 12-months, as adjudicated by a Clinical Events Committee.Time frame: From treatment - 12 months
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona · Recruiting
University of Southern California Health Sciences / Keck Hospital of USC
Los Angeles, California · Recruiting
UCSF Medical Center
San Francisco, California · Recruiting
22 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.